3D Global Biotech Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	206.74	265.69	20.63	13.64	11.08
Revenue Growth (YoY)	-22.19%	1187.67%	51.23%	23.19%	-16.48%
Cost of Revenue	58.33	91.18	15.36	10.93	9.27
Gross Profit	148.41	174.51	5.27	2.72	1.8
Selling, General & Admin	56.38	42.54	29.53	29.53	26.41
Research & Development	47.81	43.27	38.6	39.48	37.6
Operating Expenses	106.96	86.02	68.13	69	64.01
Operating Income	41.45	88.49	-62.85	-66.29	-62.21
Interest Expense	-1.4	-0.12	-0.18	-0.26	-0.26
Interest & Investment Income	13	6.19	2.24	1.68	1.35
Currency Exchange Gain (Loss)	-	1.3	0.02	-0.01	0
Other Non Operating Income (Expenses)	-0.74	0.14	1.85	0.62	0.15
EBT Excluding Unusual Items	52.31	96	-58.92	-64.25	-60.97
Gain (Loss) on Sale of Assets	-	0	-	-	-
Asset Writedown	-	-	-	-18.89	-
Other Unusual Items	-	0.07	-	0.01	-
Pretax Income	52.31	96.07	-58.92	-83.13	-60.97
Income Tax Expense	-14.22	4.37	-0.96	-16.05	-1.26
Net Income	66.53	91.7	-57.95	-67.09	-59.71
Net Income to Common	66.53	91.7	-57.95	-67.09	-59.71
Net Income Growth	-27.45%	-	-	-	-
Shares Outstanding (Basic)	77	69	56	55	54
Shares Outstanding (Diluted)	79	71	56	55	54
Shares Change (YoY)	11.87%	26.08%	2.32%	1.69%	0.77%
EPS (Basic)	0.86	1.33	-1.03	-1.22	-1.11
EPS (Diluted)	0.84	1.30	-1.03	-1.22	-1.11
EPS Growth	-35.38%	-	-	-	-
Free Cash Flow	104.74	14.91	-32.39	-35.33	-38.85
Free Cash Flow Per Share	1.32	0.21	-0.58	-0.64	-0.72
Dividend Per Share	-	0.530	-	-	-
Gross Margin	71.79%	65.68%	25.56%	19.91%	16.28%
Operating Margin	20.05%	33.31%	-304.62%	-485.87%	-561.71%
Profit Margin	32.18%	34.52%	-280.87%	-491.73%	-539.10%
Free Cash Flow Margin	50.67%	5.61%	-156.99%	-258.98%	-350.81%
EBITDA	69.1	104.62	-46.49	-47.15	-42.46
EBITDA Margin	33.43%	39.38%	-225.30%	-	-
D&A For EBITDA	27.65	16.13	16.37	19.14	19.75
EBIT	41.45	88.49	-62.85	-66.29	-62.21
EBIT Margin	20.05%	33.31%	-	-	-
Effective Tax Rate	-	4.55%	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.